Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Celera Genomics (CRA) -- Ignore unavailable to you. Want to Upgrade?

To: gao seng who wrote (461)	6/25/2000 10:08:00 PM
From: Secret_Agent_Man	Respond to of 746

The science to go forward will have winners GNSL is one with their genomic and proteomic platforms.

To: gao seng who wrote (461)	6/25/2000 10:24:00 PM
From: allen menglin chen	Read Replies (1) \| Respond to of 746

Bill must have bot some CRA stock @ 125! Party @ White House 10AM EST Monday. biz.yahoo.com Sunday June 25, 10:03 pm Eastern Time White House sets human genome announcement By Randall Mikkelsen WASHINGTON, June 25 (Reuters) - President Bill Clinton will preside over the announcement on Monday of a scientific milestone expected to eventually transform medicine: the compilation a rough map of the human genome, a White House official said. Clinton has scheduled a 10:00 a.m. EDT (1400 GMT) event at the White House to announce the breakthrough. Representatives of the two rivals racing to complete the project -- publicly funded Human Genome Project and the private Celera Genomics (NYSE:CRA - news) -- are expected to be at the ceremony. ``It essentially is to announce a dramatic breakthrough in science and one that offers a lot of possibility for improving our ... medical care,'' the official said. He said Clinton also aimed ``to make clear that the scientific work will go on in a cooperative manner and that as much information as possible will be made public so that others in the private sector and public sector can do the research that's needed to develop ... new drugs and medicines.'' The teams at Celera and the Human Genome Project have been at times competitive and at times acrimonious as they have raced to sequence and assemble the DNA that makes up the genes -- the blueprint of life. They have also haggled over whether to join forces in doing the work and publishing the results. But Clinton has taken a keen interest in the project, talking about it frequently, and has sought to bring the two sides together. Along with the work in deciphering the genome has come a controversy over whether the research could be commercialized. Clinton and British Prime Minister Tony Blair made a joint statement in March suggesting research into the genome would have to be made freely available to researchers. But Clinton said in April that a discovery with ``specific commercial application'' should be patentable. The next step, which will take years, will be sorting out which bits in this code constitute the genes and which parts are so-called ``junk'' DNA.